a Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy , University of Helsinki , Helsinki , Finland.
b Helsinki Institute of Life Science (HiLIFE) , University of Helsinki , Helsinki , Finland.
Expert Opin Drug Deliv. 2018 May;15(5):469-479. doi: 10.1080/17425247.2018.1446936. Epub 2018 Mar 6.
Nanoparticles are anticipated to overcome persistent challenges in efficient drug delivery, but the limitations associated with conventional methods of preparation are resulting in slow translation from research to clinical applications. Due to their enormous potential, microfluidic technologies have emerged as an advanced approach for the development of drug delivery systems with well-defined physicochemical characteristics and in a reproducible manner.
This review provides an overview of microfluidic devices and materials used for their manufacturing, together with the flow patterns and regimes commonly used for nanoparticle preparation. Additionally, the different geometries used in droplet microfluidics are reviewed, with particular attention to the co-flow geometry used for the production of nanoparticles. Finally, this review summarizes the main and most recent nanoparticulate systems prepared using microfluidics, including drug nanosuspensions, polymeric, lipid, structured, and theranostic nanoparticles.
The production of nanoparticles at industrial scale is still a challenge, but the microfluidic technologies bring exciting opportunities to develop drug delivery systems that can be engineered in an easy, cost-effective and reproducible manner. As a highly interdisciplinary research field, more efforts and general acceptance are needed to allow for the translation of nanoparticulate drug delivery systems from academic research to the clinical practice.
纳米粒子有望克服高效药物输送中存在的持续挑战,但由于传统制备方法的局限性,导致从研究到临床应用的转化速度缓慢。由于其巨大的潜力,微流控技术已经成为开发具有明确物理化学特性和可重复方式的药物输送系统的先进方法。
本文综述了用于制造微流控装置和材料的微流控装置和材料,以及用于制备纳米粒子的常用流动模式和状态。此外,还综述了在液滴微流控中使用的不同几何形状,特别关注用于生产纳米粒子的共流几何形状。最后,本文总结了使用微流控技术制备的主要和最新的纳米颗粒系统,包括药物纳米混悬剂、聚合物、脂质、结构和治疗性纳米颗粒。
在工业规模上生产纳米粒子仍然是一个挑战,但微流控技术为开发能够以简单、经济高效和可重复的方式进行工程设计的药物输送系统带来了令人兴奋的机会。作为一个高度跨学科的研究领域,需要更多的努力和普遍接受,才能将纳米颗粒药物输送系统从学术研究转化为临床实践。